drugset / Trial / NCT04035161

Evaluation of the Antimicrobial Effectiveness of CHG/IPA

NCT04035161

Completed 1935 enrolled Becton, Dickinson and Company
RandomizedParallel-groupSingle-blindPrevention

Summary

This single site study is a randomized, controlled, partially-blinded design enrolling a minimum of 516 healthy volunteers, where each subject will receive two of the planned study products on the product application sites of the abdomen and/or groin.

Timeline

Start
2019-04-17
Primary completion
2019-12-24
Completion
2019-12-24

Drugs

EvaluationDrugModalityDoseRoute
Subject ChloraPrep® SEPP® Unknown Topical
Subject Chlorhexidine Small molecule 2 % Topical
Subject Isopropyl Unknown 70 % Topical

Indications

No indication recorded.